Physician profile
Pooja Mally
NPI 1881856813
$3,643.19
in general payments reported to CMS, 2019-2025
16 companies · $603 in 2025
The $603 reported for 2025 was more than what a typical Ophthalmic Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $299).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.86 · 2020: $282 · 2021: $175 · 2022: $381 · 2023: $1,638 · 2024: $493 · 2025: $603.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,460 · Honoraria: $1,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.75 |
| Honoraria | $1,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $2,307.56 | 2019-2023 | Tepezza |
| Amgen INC. | $680.39 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $147.76 | 2024-2025 | Xdemvy |
| Abbvie INC. | $82.97 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $81.47 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $78.48 | 2022-2025 | |
| Alcon Vision LLC | $71.93 | 2022-2024 | Rocklatan |
| Biotissue Holdings INC. | $31.76 | 2023-2024 | |
| Oyster Point Pharma, INC. | $26.20 | 2025 | Tyrvaya |
| Dompe US, INC. | $23.78 | 2025 | Oxervate |
| Thea Pharma INC. | $23.40 | 2023 | |
| Solta Medical, A Division of Bausch Health US, LLC | $21.40 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $18.13 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $16.05 | 2024 | Tecnis Iol |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $14.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pooja Mally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.